NCT01064401 · Interventional trial
Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis
Overall registry status Completed
Phase 3
Conditions Relapsing-Remitting Multiple Sclerosis
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory